Introduction
============

Strawberry (*Fragaria X ananassa Duch*) is a very popular species cultivated in numerous countries for its fruits (culinary term) which are frequently consumed either fresh, frozen or as an additive to dairy products. Regular consumption of strawberries can have potential health promoting effects. This includes the reduction of atherosclerotic markers in subjects with metabolic syndrome^([@B1],[@B2])^ decrease in low-density lipoprotein (LDL) peroxidative damage^([@B1],[@B3],[@B4])^ and augmentation of plasma antioxidant activity.^([@B5])^ These beneficial effects can be attributed to the presence of numerous phytochemicals, mostly polyphenols with antioxidant and anti-inflammatory properties.^([@B6],[@B7])^ The most important are anthocyanins, namely pelargonidin-3-glucoside, cyanidin-3-glucoside, pelargonidin-3-rutoside and pelargonidin-3-malonyl-glucoside, as well as ellagic acid and ellagitannins.^([@B6],[@B7])^ Clinical studies with healthy subjects having a single portion of 200 to 750 g of strawberries revealed a peak in anthocyanin metabolites in plasma between 2 and 3 h after fruit consumption with subsequent normalization within an additional 6 h period.^([@B8],[@B9])^ Within 6 h after consuming strawberries, the majority of anthocyanin metabolites were excreted in urine.^([@B9],[@B10])^ These results suggest that a considerable amount of effects obtained from eating strawberries evident as a rise in circulating phenolics (e.g., augmentation of plasma antioxidant activity) is not observed after several hours in fasting plasma. However, results from studies devoted to the antioxidant effect of regular consumption of strawberries contradict this suggestion.^([@B3],[@B5])^ Studies revealed an elevated ferric reducing ability (FRAP)^([@B5])^ and increased LDL resistance to Cu^2+^-induced oxidation^([@B3])^ in fasting plasma collected several hours subsequent to the last strawberry meal. Moreover, increased FRAP persisted for 30 days after interruption of strawberry consumption.^([@B5])^ Therefore, to solve these discrepancies we examined the effects exerted on the antioxidant activity of fasting plasma (DDPH radical decomposition and FRAP) and the levels of key metabolites from anthocyanins and ellagitanins in fasting plasma and spot urine in healthy subjects consuming a daily dose of 500 g of strawberries for nine days.

Material and Methods
====================

Strawberry
----------

The strawberry "Honeoye" fruits were harvested at commercial maturity at a plantation managed according to organic standards located near Skierniewice (Poland). Strawberries were washed, destemmed, mixed to achieve a uniform experimental sample, frozen, disintegrated at −25°C, then packed in polyethylene (PE) bags in quantities of 500 ± 1 g and stored (not exceeding 3 months) at the same temperature (−25°C) until further consumption (Table [1](#T1){ref-type="table"}).

Study population
----------------

The study group involved 10 volunteers (6 men, mean age 41 ± 6 years, mean body weight 74.4 ± 8.7 kg, mean body mass index 24.1 ± 2.6 kg/m^2^). The inclusion criteria were an age between 35 and 50 years and a written informed consent before entering the study. The control group consisted of 7 subjects (4 men, mean age 46 ± 6 years, mean body weight 77.4 ± 6.8 kg, mean body mass index 25.6 ± 1.6 kg/m^2^). All volunteers were members of the scientific staff of the Medical University of Lodz. They were apparently healthy nonsmokers and agreed to comply with dietary instructions related to their participation in the study. The exclusion criteria included: pregnancy, alcohol and illicit drug abuse, fructose intolerance, strawberry hypersensitivity, any history of infectious and inflammatory diseases, use of any vitamins, food supplements or any systemic treatment with antibiotics within 3 months prior to the study.

Study protocol
--------------

They study had an open label with a run-in and wash-out period design and consisted of 7 visits on the 0th, 3rd, 6th, 9th, 12th, 15th and the 21st day of the trial. During the study period (21 days), volunteers (study group and control group) did not consume any fruits (fresh, frozen, dried, canned), products containing fruits (e.g., jams, yogurts), fruit juices, nuts, chocolate, coffee, cocoa, wine and beer. Consumption of tea was limited to 3 cups per day. Ingestion of vegetables was allowed and volunteers were asked to maintain it on the usual level during the study period. After a 6 day run-in period, volunteers from study group commenced (visit on the 6th day) a daily consumption of 500 g of strawberries (unfrozen at room temperature and consumed between 11.00--14.00 h) for 9 days pending a visit on the 15th day. The wash-out period from the 15th day visit lasted 6 days (visit on the 21st day). Spot morning urine (10 ml) was collected between 6:30--7:30 a.m. Visits took place between 8:30--9:30 a.m. Fasting venous blood (10 ml) was collected (EDTA-K2 Vacutest tubes) then centrifuged (10 min, 1,500 × g, 4°C). Obtained plasma was stored (not exceeding 3 months) at --80°C until assay. Urine was also centrifuged and stored under equal conditions. At the first visit, volunteers received a diary card to record daily consumption of selected food products and beverages rich in polyphenols and all complaints, especially related to inflammatory and infectious disorders, as well as any medications and supplements that may have affected oxidant/antioxidant balance in the blood. This was reviewed by investigators in respect to continuation or a subject withdrawal from the study during each subsequent visit. Control subjects were asked to obey all dietary restrictions, however, they did not consume strawberries. The Medical University of Lodz Ethics Committee approved the study protocol (approval RNN/62/09/KE).

Determination of selected phenolics in human plasma and urine
-------------------------------------------------------------

All chemicals, buffers and water used throughout the study were of HPLC grade. 3,4-dihydroxyphenylacetic acid, dihydrocaffeic acid, vanillic acid, caffeic acid and homovanillic acid were determined by HPLC with electrochemical detection (HPLC-ECD) while hippuric acid, 3-hydroxyhippuric, 4-hydroxyhippuric, 3,4-dihydroxybenzoic acid, chlorogenic acid, ellagic acid and urolithin A were determined by HPLC with UV/VIS detection (HPLC-UV/VIS). HPLC-ECD: the equipment was composed of P580 HPLC pump (Dionex, Sunnyvale, CA); Hypersil BDS C18 column (150 × 2.1 mm ID, 3-µm particles), an electrochemical detector with a flow-through detection cell equipped with a glass carbon electrode, and an Ag/AgCl reference one, set at +0.82 V with a working temperature of 32°C (Decade, Antec Leyden, Netherlands), degasser (Biotech model 2003), universal chromatography interface (UCI-100 Dionex) and a 20-µl manual injector. The mobile phase was prepared by the addition of 0.75 g KH~2~PO~4~, 40 mg EDTA, 3 ml 1 mol/L H~3~PO~4~ and 45 ml of methanol to 440 ml of water, the pH was then adjusted to 2.80 with a concentrated CH~3~COOH with its volume filled up to 500 ml with water. HPLC-UV/VIS: the equipment was composed of an P580 HPLC pump; Phenomenex HPLC column (Synergi 4 µm Fusion -- RP 80 A), column oven (STH 585 Dionex) set at a working temperature of 25°C, a diode array detector (wavelengths 210, 280 and 325 nm, UVD340 U Dionex) and an automated sample injector (ASI-100 Dionex). Plasma samples (0.5 ml) were mixed with 50 µl of a 0.78 M acetate buffer (pH 5.2), 25 µl of a 20% ascorbic acid solution, 10 µl of a 2 mg/L fisetyn solution, 10 µl of β-glucuronidase (from bovine liver, type B-3) in a 0.1 M acetate buffer (4,000 U/ml, pH 5.2), and 10 µl of sulphatase (from Helix pomatia, type H-1) solution in a 0.1 M acetate buffer (1,028 U/ml, pH 5.2) (Sigma-Aldrich Chemical, St. Louis, MO) and incubated for 60 min at 37°C. Then, 0.5 ml of a 1 M solution of phosphoric acid was added. The sample was again incubated for 10 min at 37°C, then mixed with 0.5 ml of water and poured into a Speedisk^®^ Column H~2~O-Phobic DVB (3 ml Solid Phase Extraction Column 50 mg per column,15 µm particle diameter J.T. Baker, Phillipsburg, NJ) preconditioned with 1 ml of methanol and 0.5 ml of water. The column was washed 3 times with 0.5 ml of water, dried under a vacuum, and eluted with 0.4 ml of methanol. Then 50 µl of the eluate was mixed with 450 µl of mobile phase and 20 µl samples of these solutions were subjected to isocratic analysis with HPLC-ECD. The flow rate of the mobile phase was kept constant at 0.20 ml/min and the total run time was 90 min. Samples of methanol eluate from Speedisk^®^ Column (5 µl) were also analyzed with gradient elution HPLC-UV/VIS and flow rate 0.25 ml/min. The mobile phase consisted of solvent A (0.05% aqueous solution of H~3~PO~4~) and solvent B (0.05% solution of H~3~PO~4~ in acetonitrile). The system was ran with a gradient program: 4--15% B (v/v) (0--8 min), 15--40% B (15 min), 40--50% B (6 min), 50% B (1 min), 50--4% B (1 min), and 4% B (10 min). Urine samples (4 ml) were mixed with 0.5 ml of 0.78 M acetate buffer (pH 5.2), 40 µl of β-glucuronidase solution in 0.1 M acetate buffer (4,000 U/ml), and 40 µl of sulphatase solution in 0.1 M acetate buffer (1,028 U/ml) and incubated for 60 min at 37°C. Then, 0.5 ml of 1 M solution of phosphoric acid was added. The sample was again incubated for 10 min at 37°C, mixed with 0.5 ml of water and poured into a Bakerbond SPE C18 500 mg/3 ml column (J.T. Baker, Phillipsburg, NJ) preconditioned with 3 ml of methanol and 10 ml of water. The column was washed 2 times with 1.5 ml of water and then eluted with 9 ml of 0.1 M acetate buffer (pH = 5.2), dried under a vacuum, and eluted again with 3.0 ml of methanol. Caffeic acid, homovanillic acid and ellagic acid were determined in methanol eluate while the remaining compounds were determined in the acetate buffer eluate. Two hundred µl of acetate buffer eluate was mixed with 200 µl of mobile phase (solvent A) and 5 µl of this solution was analyzed with HPLC-UV/VIS: flow rate 0.25 ml/min, and gradient program: 4--10% B (v/v) (0--8 min), 10--40% B (12 min), 40% B (3 min), 40--4% B (2 min), and 4% B (10 min). Gradient program: 4--15% B (v/v) (0--8 min), 15--40% B (19 min), 40--50% B (6 min), 50% B (1 min), 50--4% B (1 min), and 4% B (10 min) was instead used for analysis of 5 µl of methanol eluate. HPLC-ECD: 10 µl of acetate buffer eluate or methanol eluate was mixed with 490 µl of mobile phase. 20 µl of this solution was analyzed as described for plasma specimens. Chromeleon software (Dionex, Sunnyvale, CA) was used for chromatographic data collection and calculation of concentrations of phenolics. Identification of particular compounds were conducted on the basis of their spectral characteristics and retention times in comparison to corresponding standard substances. All standards were from Sigma-Aldrich Chemie GmbH (Steinheim, Germany) or from Fluka Sigma-Aldrich (Buchs, Steinheim, Germany) except for urolithin A that was a generous gift from professor B. Krol (Institute of Chemical Technology of Food, Technical University of Lodz). Individual results were obtained as a mean from duplicate measurements and expressed in µM and µmol/g of creatinine. The detection and determination limits and recovery of phenolics from SPE columns are shown in Table [2](#T2){ref-type="table"}.

Measurement of plasma DPPH radical- scavenging activity
-------------------------------------------------------

Plasma DPPH radical-scavenging activity (DPPH test) was determined following our procedure^([@B11])^: 5 µl of 10 mM of a DPPH radical solution in methanol was added to a cuvette containing 0.970 ml of methanol and continuously stirred. Then, after a 3 min incubation period at 20°C, the baseline absorbance at wavelength 517 nm (A517) was measured with an Ultrospec III, using Spectro-Kinetics software (LKB Biochrom Pharmacia, Cambridge, England). Afterward, 25 µl of deproteinized plasma was added, mixed, and the A517 decrease related to the DPPH radical decomposition over 30 min of incubation period was then recorded. Negative control samples were 25 µl of 9.50 M acetonitrile solution. All individual results were obtained from duplicate measurements and plasma scavenging effect (Sc%) was calculated according to the formula Sc% = (1 − A517 plasma sample/A517 negative control) × 100%. The coefficient of variation was 4.2% and detection limit was 0.50% of the initial amount of decomposed DPPH radical over 30 min of incubation.^([@B11])^ Plasma specimens were deproteinized by mixing with an equal volume of acetonitrile. They were centrifuged (10 min, 4°C, 9,500 × g) after 2 min incubation at 20°C. Supernatant (deproteinized plasma) was collected and stored at --80°C until assay. Part of plasma samples (200 µl) was incubated with 1.2 U/ml uricase and 24 U/ml catalase (Sigma-Aldrich Chemical, St. Louis, MO) for 10 min at 37°C and then deproteinized with acetonitrile. Preliminary experiments with six plasma specimens with uric acid concentration ranging from 5.2 to 6.8 mg/dl revealed complete decomposition of uric acid already after 5 min from uricase addition. Catalase was added for rapid decomposition of H~2~O~2~ (generated during uricase-catalyzed oxidation of uric acid by oxygen) to prevent suppression of plasma antioxidant activity. Catalase alone did not change plasma DPPH radical scavenging activity.

Other determinations
--------------------

Plasma uric acid and urinary creatinine were determined with an Alpha Diagnostics Creatinine kit and an Alpha Diagnostics Uric Acid kit (Alpha Diagnostics, Warsaw Poland). Total phenolic compound concentrations in plasma and urine was measured by the Folin-Ciocalteau method^([@B12])^ and expressed in catechin equivalent µmol/l and µmol/g of creatinine, respectively. Strawberry phenolics were determined with HPLC method according to previously described protocols.^([@B13]--[@B15])^ Fruits glucose, fructose and saccharose were determined with combination of SPE and HPLC techniques.^([@B16])^ Ferric reducing ability (FRAP) of fasting native plasma (containing uric acid) and non-urate plasma (pre-treated with uricase and catalase) was evaluated according to the method of Benzie and Strain^([@B17])^ with some modifications.^([@B12])^ Individual results were obtained from duplicate experiments and were expressed as a concentration of Fe^3+^ ions reduced into Fe^2+^ after 3 min of incubation of plasma samples with FRAP reagent.^([@B12])^

Statistical analysis
--------------------

Results were expressed as mean ± SD and median. ANOVA for repeated observations or Friedman's ANOVA was applied to assess changes in the variables of our interest over time (before, during and after consumption of strawberries) depending on data distribution tested with Shapiro-Wilk W test. In the presence of significant changes, the post-hoc analyses were done with Scheffe's test or post-hoc analysis for Friedman's ANOVA (multiple comparisons at 2 different time-points). Differences between groups (strawberry consumers versus control subjects) were assessed using ANOVA for independent variables. A *p* value of \<0.05 was considered significant.

Results
=======

All subjects completed the study and no protocol violations were noted by investigators. Average consumption (calculated on the basis of subjects reports) of vegetables, meat, fats, oils, eggs and dairy products as well as the self assessed ingested caloric load and number of meals per day did not change in the strawberry consumers as well as in the control group over the study period (data not shown). Daily consumption of tea did not exceed 3 cups in both groups.

Effect of strawberry consumption on fasting plasma DPPH radical scavenging activity
-----------------------------------------------------------------------------------

Plasma DPPH radical scavenging activity and uric acid levels were similar in both groups and did not change during the study period (Table [3](#T3){ref-type="table"}). However, plasma specimens deprived of uric acid revealed significant changes in antioxidant activity in strawberry consumers (Fig. [1](#F1){ref-type="fig"}). During the run-in period, the mean DPPH radical scavenging activity of non-urate plasma decreased from 6.3 ± 0.8; median 6.3% to 5.7 ± 0.6; median 5.7% (*p*\<0.01) and after the introduction of strawberries to the diet, it rose to a maximal value of 6.6 ± 0.6; median 6.5% on the 9th day. After 6 days of the wash-out period, the antioxidant activity declined to values observed at the end of the run in period (Fig. [1](#F1){ref-type="fig"}). In the control group, similar decline (although not significant) of non-urate plasma DPPH radical activity was noted during the run-in period with stable values at the remaining time-points.

Effect of strawberry consumption on ferric reducing ability of plasma (FRAP)
----------------------------------------------------------------------------

Fasting FRAP was similar in strawberry consumers and controls and no within- and between-groups changes were noted during the study period (Table [3](#T3){ref-type="table"}). Similarly, non-urate FRAP did not differ between controls and strawberry consumers at all time-points. Although mean non-urate FRAP at the 9th day (after 3 days of strawberry consumption) was about 1.2-times higher than that the one at the 0th day, this difference did not reach statistical significance (*p*\>0.05).

Concentrations of selected phenolics in fasting plasma
------------------------------------------------------

The mean concentrations of total plasma phenolics were similar and stable in both groups (Table [3](#T3){ref-type="table"}). Urolithin A, ellagic acid, 3.4-dihydroxybenzoic acid and 3-hydroxyhippuric acid were never detected in fasting plasma. Other compounds such as 4-hydroxyhippuric acid, dihydrocaffeic acid, caffeic acid, homovanillic acid, vanillic acid, 3,4-dihydroxyphenylacetic acid (Table [4](#T4){ref-type="table"}), and hippuric acid (data not shown) were measured. However, their concentrations did not change significantly in strawberry consumers (Table [4](#T4){ref-type="table"}) as well as in controls (data not shown) throughout the study period.

Concentration of selected phenolics in spot urine
-------------------------------------------------

There were no significant changes in the total concentrations of phenolics in spot urine in strawberry consumers and controls throughout the study period (Table [3](#T3){ref-type="table"}). The concentration of urolithin A and 4-hydroxyhippuric acid in spot urine were significantly raised in response to the introduction of strawberries to the diet (Fig. [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). After 3 and 6 days of strawberry consumption, the mean urinary concentration of urolithin A was 9.3- (95.3 ± 61.7; median 101.1 µmol/g of creatinine) and 8.7-times higher (88.3 ± 63.9; median 77.3 µmol/g of creatinine) (*p*\<0.05) than that observed in spot urine collected on the 6th day (10.2 ± 31.5; median 0.0 µmol/g of creatinine) (about 4 h before the first portion of strawberry was consumed). Although, on the 15th day (9 days of strawberry ingestion) urinary urolithin A was 6.5-times higher than that at the end of the run-in period (66.8 ± 37.3; median 63.8 vs 10.2 ± 31.5; median 0.0 µmol/g of creatinine), this did not reach statistical significance. Withdrawal of strawberries resulted in a decrease in the urinary levels of urolithin A and at the end of the wash-out, its concentration was practically equal to that of baseline (Fig. [2](#F2){ref-type="fig"}). Urinary urolithin A levels were low and stable in control subjects. At the 9th and 12th day they reached 0.63 ± 1.21; median 0.0 and 0.34 ± 0.56; median 0.0 µmol/g of creatinine and were significantly lower (*p*\<0.05) than those in strawberry consumers (Fig. [2](#F2){ref-type="fig"}). During the run-in period, the mean concentration of 4-hydroxyhippuric acid decreased about 2.5-times (79.2 ± 95.9; median 43.5 µmol/g of creatinine on day 0 vs 31.3 ± 32.3; median 27.2 µmol/g of creatinine on the 6th day). When volunteers began ingesting strawberries, the urinary levels of 4-hydroxyhippuric acid rose, reaching a maximal value after 6 days (185.4 ± 130.2; median 146.8 µmol/g of creatinine) then significantly decreased despite the ingestion of fruits (15th day). There were significant differences (*p*\<0.05) in urinary levels of 4-hydroxyhippuric acid between strawberry consumers and controls at the 9th and 12th day (Fig. [3](#F3){ref-type="fig"}). In like manner to urolithin A, the concentration of 4-hydroxyhippuric acid decreased during the wash-out period until values were similar to those noted at the end of the run-in period. The concentration of chlorogenic acid at the end of the study was significantly lower from that of the 0th and 9th day among strawberry consumers (Table [5](#T5){ref-type="table"}). Urinary concentrations of hipuric acid, dihydrocaffeic acid, caffeic acid, vanillic acid, homovanillic acid, 3,4-dihydroxyphenylacetic acid and 3-hydroxyhippuric acid were stable in controls (data not shown) and did not change in response to strawberry consumption (Table [5](#T5){ref-type="table"}). Ellagic acid was never detected in any spot urine sample. The vast majority of urine samples obtained from strawberry consumers were negative for the presence of 3,4-dihydroxybenzoic acid. This compound was only detected in 8 samples: 2 on the 0th, 1 sample on the 3rd, 9th and 12th day and in 3 samples on the 15th day, respectively. The concentration of 3,4-dihydroxybenzoic acid ranged from 20.9 to 137.1 µmol/g of creatinine.

Discussion
==========

Daily consumption of 500 g of strawberries for 9 days did not increase the concentration of every phenolic studied in fasting plasma. To the exclusion of everything else, the concentration of urolithin A and 4-hydroxyhippuric acid were raised significantly in spot urine after strawberry intake. Despite the stable levels of phenolics, samples of fasting plasma deprived of uric acid revealed a significant increase in the DPPH radical scavenging activity in response to strawberry consumption. Contrary to this, the antioxidant activity (DPPH test and FRAP) of native (untreated with uricase) fasting plasma specimens did not change over the study period. Moreover, the non-urate FRAP did not alter significantly after consumption of strawberries. In addition, control subjects that did not consume strawberries had stable antioxidant activity (DPPH test and FRAP) of both native and non-urate plasma samples. This implies that diet supplementation with strawberries was the cause of augmentation of non-urate plasma ability to decompose the DPPH radical in the studied group. Analysis of plasma samples deprived of uric acid (non-urate plasma) is an approach that increases the sensitivity of monitoring dietary interventions on antioxidant activity in blood.^([@B18])^ Uric acid contributes considerably to the plasma antioxidant activity.^([@B11],[@B18])^ Moreover, plasma antioxidant activity expressed as the ability to decompose the DPPH radical or FRAP strongly correlated with urate levels.^([@B12])^ In addition, positive linear correlation between FRAP and plasma DPPH radical scavenging activity was observed in healthy subjects.^([@B11])^ Therefore, uric acid can mask any augmentation in the antioxidant potential related to a moderate increase in circulating low molecular weight antioxidants.

Bearing this in mind, one may expect that since strawberries induced increase in non-urate DPPH radical scavenging activity, this would be accompanied by the augmentation of non-urate FRAP. However, the non-urate FRAP did not alter significantly in strawberry consumers.

The mean contribution of uric acid to FRAP and plasma activity to decompose the DPPH radical in strawberry consumers group at the 0th day was 61% and 75%, respectively, as derived from data shown in Table [3](#T3){ref-type="table"} and Fig. [1](#F1){ref-type="fig"}. Therefore, even mild increase in circulating antioxidants could augment to a greater extent the non-urate plasma DPPH radical scavenging activity than the non-urate FRAP. This could be a plausible explanation of the different effect of strawberry consumption on the non-urate plasma antioxidant activity measured with DPPH test and FRAP method. On the other hand, this may result just from different principles of these two methods for assessment of plasma antioxidant capacity: reaction with stable free radical in the case of DPPH test and reduction of Fe^3+^ ions in the FRAP assay.

Although fasting levels of polyphenols did not alter from baseline, it is possible that strawberry ingestion transiently elevated circulating phenolics. Vanillic acid, 4-hydroxybenzoic acid and 3,4-dihydroxybenzoic acid peaked in plasma within 3 h after a single consumption of 750 g of strawberries in healthy subjects.^([@B9])^ Similar results were noted after a dose of 300 g of fruits with normalization in the levels of phenolics within 6 additional hours.^([@B19])^ These can spare the low molecular weight antioxidants in plasma and thus probably cause a moderate rise in the fasting non-urate plasma DPPH radical scavenging activity. We used relatively unspecific analytical methods (HPLC-UV/VIS and HPLC-ECD) for selected phenolics determination in plasma and urine samples. Application of HPLC with mass spectrometric detection gives opportunity to identify and measure much more phenolic metabolites related to strawberry intake. Therefore, it can not be excluded that some phenolics rose in fasting plasma after strawberry intake and enhanced its non-urate antioxidant activity measured with the DPPH test. Daily ingestion of ascorbic acid with strawberry consumption was about 214 mg. Since *in vitro* ascorbic acid can decompose the DPPH radical,^([@B11])^ this could lead to an augmentation in the plasma antioxidant activity *in vivo*. Although we did not monitor plasma ascorbic acid levels, previous clinical trials concerning the effect of this vitamin on antioxidant activity rather excludes explanation. Plasma FRAP did not change significantly after ingestion of a single dose of 500 mg of ascorbic acid in healthy subjects.^([@B20])^ Similarly, an oral dose of 1,200 mg of ascorbic acid did not change FRAP 4 h post ingestion, nevertheless, enzymatic removal of uric acid revealed a significant increment (about 12%) in the antioxidant activity in a group of five healthy volunteers.^([@B18])^ In our study, the dose of vitamin C ingested with a portion of strawberry was 2.5- and 5.6-times lower than that of the previously described experiments and fasting plasma was collected at least 18 h after the consumption of fruits. It would therefore seem that, the increase in ascorbic acid was not a direct culprit of strawberry-induced augmentation in non-urate plasma DPPH radical scavenging activity.

Six day wash-out decreased the non-urate plasma antioxidant activity to a baseline value in the strawberry consumers. This and especially no changes in FRAP disagrees with the observation of elevated fasting plasma FRAP after a 1 month wash-out preceded by a 16-day daily consumption of 500 g of strawberries.^([@B5])^ Moreover, this study described significant FRAP increase (by 8.5%) already after 4 days of fruits intake that was also elevated for the remaining days of diet supplementation with strawberries (the 8th, 12th and 16th day).^([@B5])^ The specific study protocol of Tulipani *et al.*^([@B5])^ report may explain these discrepancies: A---during the 10-day pre-study and 16-day strawberry consumption periods subjects were on a restrictive low polyphenolics diet (without fruit and vegetables, jams, nuts, honey, chocolate and cocoa derivatives, wine, beer, tea, fruit juices), and under such restrictions one may expect a stronger effect of strawberries on plasma antioxidant activity; B---they did not measure non-urate FRAP, and at the end of the wash-out period plasma uric acid levels were elevated by approximately 5.4% from baseline, probably being the cause for the increased FRAP at this time-point; C---they rather used over-optimistic statistical method (just the Wilcoxon paired samples test) for data analysis. The study protocol and obtained data in that study could be recognized as repeated measures design.^([@B21])^ These data should be analyzed with proper statistical tools in order to assess changes in the variables over time, and secondly, in case of significance, to compare values at two different time-points with appropriate post-hoc tests.

Although majority of phenolic metabolites related to the ingestion of a single dose of strawberries were excreted in the urine within several hours^([@B22],[@B23])^ we observed increased concentrations of urolithin A and 4-hydroxyhippuric acid in spot morning urine of strawberry consumers. Dietary polyphenols are transformed into less complex compounds by the gut microflora before absorption into the bloodstream.^([@B24])^ 3,4-dihydroxybenzoic acid and 4-hydroxybenzoic acid are the products of the microbial conversion of cyanidin and pelargonidin, respectively.^([@B22],[@B24])^ Ellagitannins and ellagic acid are metabolized to urolithin A and B.^([@B19],[@B23])^ 4-hydroxybenzoic acid can undergo glycination in the liver to form 4-hydroxyhippuric acid which can be subsequently excreted in the urine.^([@B25])^ Based on Table [1](#T1){ref-type="table"}, daily ingestion of pelargonidin molecules with a portion of strawberries were about 90-times higher than that of cyanidin. This may explain why the concentration of 4-hydroxyhippuric acid in spot urine rose significantly in response to strawberry consumption, whereas the levels of 3,4-dihydroxybenzoic acid were only occasionally detected in a few samples. The molar content of ellagic acid in strawberries was the second highest after pelargonidin, explaining the elevated excretion of urolithin A with spot urine.

Although our subjects were on semi-restrictive diet (allowing consumption of vegetables but no fruits and polyphenols rich beverages), we did not observe any significant changes of total phenolics concentration in plasma and spot urine. Therefore, it seems that positive effect of strawberry consumption on non-urate fasting plasma antioxidant activity measured with DPPH test could be achieved in subjects without any dietary restrictions. However, this requires further studies.

In conclusion, we found that 500 g of daily strawberry consumption raised the fasting non-urate plasma DPPH radical scavenging in healthy subjects. This may decrease the risk of systemic imbalance between oxidants and anti-oxidants and be one of the mechanisms of health-promoting effect of this fruit consuming.
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![Effect of strawberry consumption (500 g of fruits daily for 9 days) on the non-urate plasma DPPH radical scavenging activity in healthy subjects (closed circles, *n* = 10). After a 6 day run-in period volunteers started to consume 500 g of strawberries daily (the first dose on the 6th day and the last dose on the 14th day). On the 15th day, strawberries were withdrawn and subjects entered a wash-out period lasting until the 21st day. Control subjects (open circles, *n* = 7) did not consume strawberries. Fasting plasma samples were treated with uricase and catalase in order to decompose the uric acid. After subsequent deproteinization with acetonitrile the DPPH radical scavenging activity was measured and expressed (mean, SD) as % of decomposed initial amount of DPPH radical over 30 min incubation. \* vs the 3rd, 6th, and 21st day---*p*\<0.01, ^†^ vs the 3rd and 6th day---*p*\<0.01.](jcbn13-93f01){#F1}

![Effect of strawberry consumption (500 g of fruits per day for 9 days) on the concentrations of urolithin A (open circles) in morning spot urine of healthy subjects (*n* = 10). Control subjects (closed circles, *n* = 7) did not consume strawberries. Results (mean ± SD) are expressed in µmol/g of creatinine. Other details as for Fig. [1](#F1){ref-type="fig"}. ^†^ vs the 0th, 3rd and 6th day within strawberry group---*p*\<0.05, \* vs the 0th, 3rd, 6th and 21st day within strawberry group---*p*\<0.05, ^\#^ vs corresponding value of controls (the 9th and 12th day)---*p*\<0.05.](jcbn13-93f02){#F2}

![Effect of strawberry consumption (500 g of fruits per day for 9 days) on the concentrations of 4-hydroxyhippuric acid (closed squares) in morning spot urine of healthy subjects (*n* = 10). Control subjects (open squares, *n* = 7) did not consume strawberries. Results (mean ± SD) are expressed in µmol/g of creatinine. Other details as for Fig. [1](#F1){ref-type="fig"}. \* vs the 0th, 3rd, 6th and 21st day---*p*\<0.05, ^\#^ vs the 6th day---*p*\<0.05, \*\* vs the 12th day---*p*\<0.05 within the strawberry group, respectively. ^†^ vs corresponding value of controls (the 9th and 12th day)---*p*\<0.05.](jcbn13-93f03){#F3}

###### 

Characteristics of the studied strawberry fruit "Honeoye"

  ------------------------------------------------------ ------------------------
  Dry matter (%)                                         11.2 ± 1.4
  Saccharose (g/100 g)                                   0.37 ± 0.01
  Glucose (g/100 g)                                      3.52 ± 1.3
  Fructose (g/100 g)                                     3.90 ± 0.7
  Ascorbic acid (mg/100 g)                               42.7 ± 1.1
  Malic acid (mg/100 g)                                  244 ± 5
  Citric acid (mg/100 g)                                 898 ± 29
  Total anthocyanins (mg/100 g)                          108.9 ± 3.5
  Cyanidin 3-*O*-glucoside (mg/100 g)                    1.1 ± 0.0 (2.4)
  Pelargonidin 3-*O*-glucoside (mg/100 g)                91.3 ± 2.9 (210.8)
  Pelargonidin 3-*O*-rutinoside (mg/100 g)               2.7 ± 0.1 (4.7)
  Cyanidin 3-*O*-(6''-malony-glucoside) (mg/100 g)       0.2 ± 0.0 (0.4)
  Pelargonidin 3-*O*-(6''-malony-glucoside) (mg/100 g)   12.7 ± 0.4 (24.5)
  Total phenolic compounds (mg/100 g)                    253 ± 5
  Chlorogenic acid and derivatives (mg/100 g)            0.39 ± 0.01 (1.1)\*
  p-Coumaric acid and derivatives (mg/100 g)             5.98 ± 0.10 (36.5)\*\*
  Ellagic acid (mg/100 g)                                17.3 ± 0.4 (57.3)
  Quercetin glycosides (mg/100 g)                        4.30 ± 0.09
  Keampferol glycosides (mg/100 g)                       4.41 ± 0.04
  Catechin (mg/100 g)                                    1.8 ± 0.2 (6.2)
  Epicatechin (mg/100 g)                                 1.5 ± 0.2 (5.2)
  Procyanidins (mg/100 g)                                108 ± 4
  ------------------------------------------------------ ------------------------

Results obtained from 10 separate measurements with randomly collected specimens of disintegrated fruits just before packing to PE bags. In parentheses, content expressed in µmoles per 100 g of strawberries. \*, \*\* calculation was based on the molecular weight of chlorogenic acid and p-coumaric acid, respectively. The decrease in the content of polyphenols in the strawberry pulp during 3 month storage at --25°C did not exceeded 4% for all compounds specified in the table.

###### 

The detection and determination limits of phenolics measurement with HPLC and the recovery from SPE column

  Analyzed compound              Detection limit (µmol/L)   Determination limit (µmol/L)   Recovery from SPE column (%)   
  ------------------------------ -------------------------- ------------------------------ ------------------------------ ---------
  DOPAC^A^                       0.03 ± 0.00                0.05 ± 0.01                    96 ± 5                         98 ± 4
  Vanillic acid^A^               0.02 ± 0.00                0.08 ± 0.01                    97 ± 4                         67 ± 5
  Caffeic acid^A^                0.01 ± 0.00                0.03 ± 0.00                    98 ± 5                         68 ± 6
  Dihydrocaffeic^A^              0.02 ± 0.00                0.08 ± 0.01                    98 ± 4                         66 ± 5
  Homovanillic acid^A^           0.01 ± 0.00                0.03 ± 0.00                    96 ± 5                         64 ± 6
  Chlorogenic acid^B^            1.10 ± 0.07                3.34 ± 0.11                    ND                             100 ± 4
  Hippuric acid^B^               2.60 ± 0.11                7.90 ± 0.13                    99 ± 6                         85 ± 6
  4-hydroxyhippuric acid^B^      1.19 ± 0.05                3.62 ± 0.09                    93 ± 5                         96 ± 4
  3-hydroxyhippuric acid^B^      0.70 ± 0.05                2.11 ± 0.12                    99 ± 4                         94 ± 5
  Ellagic acid^B^                1.21 ± 0.09                3.65 ± 0.15                    97 ± 6                         41 ± 6
  Urolithin A^B^                 0.36 ± 0.07                1.10 ± 0.06                    67 ± 4                         97 ± 6
  3,4-dihydroxybenzoic acid^B^   1.39 ± 0.06                4.21 ± 0.18                    100 ± 6                        80 ± 5

SPE, solid phase extraction; DOPAC, 3,4-dihydroxyphenylacetic acid; ^A^determined with HPLC-ECD, ^B^determined with HPLC-UV/VIS. ND, not determined. Values represent the mean of 3 series of experiments.

###### 

Plasma DPPH radical scavenging activity, ferric reducing ability of plasma (FRAP), uric acid levels and total phenolics concentration in fasting plasma and spot morning urine in strawberry consumers (studied group) and in controls over the study period

  Variable                            Subject group         Day of the study                                                                                                                    
  ----------------------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  Sc%                                 Studied               25.7 ± 4.9 (24.8)     26.2 ± 5.6 (25.7)     26.5 ± 5.6 (26.0)     26.5 ± 5.1 (25.4)     27.1 ± 5.7 (26.8)     26.1 ± 5.3 (26.8)     25.7 ± 5.1 (24.9)
                                                                                                                                                                                                
  Control                             25.6 ± 6.6 (24.5)     25.6 ± 5.7 (24.9)     27.5 ± 7.0 (26.3)     26.4 ± 6.5 (25.1)     25.7 ± 5.8 (24.9)     26.5 ± 5.5 (25.3)     24.1 ± 6.1 (23.8)     
                                                                                                                                                                                                
  FRAP (µmol/L)                       Studied               1,511 ± 213 (1,462)   1,475 ± 340 (1,403)   1,510 ± 242 (1,465)   1,538 ± 261 (1,497)   1,564 ± 295 (1,570)   1,561 ± 240 (1,596)   1,533 ± 231 (1,498)
                                                                                                                                                                                                
  Control                             1,563 ± 178 (1,486)   1,494 ± 269 (1,452)   1,492 ± 212 (1,439)   1,506 ± 321 (1,420)   1,578 ± 189 (1,523)   1,554 ± 265 (1,498)   1,512 ± 225 (1,486)   
                                                                                                                                                                                                
  Non-urate FRAP (µmol/L)             Studied               591 ± 82 (573)        618 ± 91 (586)        656 ± 72 (634)        705 ± 96 (680)        650 ± 108 (651)       658 ± 75 (669)        668 ± 98 (651)
                                                                                                                                                                                                
  Control                             608 ± 69 (545)        598 ± 104 (536)       612 ± 89 (576)        583 ± 112 (545)       598 ± 74 (562)        578 ± 92 (542)        586 ± 77 (549)        
                                                                                                                                                                                                
  Uric acid (mg/dL)                   Studied               4.2 ± 0.8 (4.1)       4.5 ± 1.3 (4.3)       4.9 ± 1.3 (4.8)       4.2 ± 1.3 (4.0)       4.0 ± 1.5 (3.9)       4.2 ± 1.5 (4.1)       4.5 ± 1.2 (4.4)
                                                                                                                                                                                                
  Control                             4.5 ± 0.7 (4.3)       4.4 ± 0.6 (4.2)       4.7 ± 0.9 (4.5)       4.8 ± 1.2 (4.7)       4.6 ± 1.1 (4.4)       4.7 ± 0.9 (4.6)       4.6 ± 0.9 (4.3)       
                                                                                                                                                                                                
  Plasma TP (mmol/L)                  Studied               0.75 ± 0.09 (0.71)    0.75 ± 0.08 (0.73)    0.74 ± 0.09 (0.72)    0.76 ± 0.11 (0.73)    0.78 ± 0.08 (0.74)    0.79 ± 0.09 (0.76)    0.77 ± 0.10 (0.75)
                                                                                                                                                                                                
  Control                             0.74 ± 0.13 (0.72)    0.74 ± 0.09 (0.71)    0.77 ± 0.12 (0.74)    0.76 ± 0.11 (0.73)    0.80 ± 0.12 (0.77)    0.78 ± 0.14 (0.74)    0.79 ± 0.13 (0.75)    
                                                                                                                                                                                                
  Urinary TP (mmol/g of creatinine)   Studied               1.47 ± 0.55 (1.29)    1.02 ± 0.21 (0.96)    1.22 ± 0.22 (1.12)    1.39 ± 0.35 (1.21)    1.45 ± 0.34 (1.32)    1.29 ± 0.22 (1.16)    1.41 ± 0.35 (1.33)
                                                                                                                                                                                                
  Control                             1.31 ± 0.72 (1.12)    1.18 ± 0.67 (1.02)    0.99 ± 0.22 (0.87)    0.85 ± 0.19 (0.74)    1.11 ± 0.28 (0.82)    1.03 ± 0.22 (0.91)    1.07 ± 0.40 (0.90)    

Sc%, % of the initial amount of decomposed DPPH radical by deproteinized plasma; TP, total phenolics. After a 6 day run-in period volunteers (studied group, *n* = 10) started to consume 500 g of strawberries daily (the first dose on the 6th day and the last dose on the 14th day). On the 15th day, strawberries were withdrawn and subjects entered a wash-out period lasting until the 21st day. Controls (*n* = 7) did not consume strawberries. Both groups were on semi-restrictive diet (without fruits, nuts, chocolate, coffee, cocoa, wine and beer) over the whole study period. Median value showed in parentheses. No significant changes were found.

###### 

Concentration of selected phenolic acids in fasting plasma of strawberry consumers over the study period

  Phenolic acid (µmol/L)   Day of the study                                                                                                              
  ------------------------ -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
  4-hydroxyhippuric        3.87 ± 3.44 (3.76)   3.76 ± 3.44 (3.65)   3.33 ± 2.79 (3.23)   3.44 ± 3.01 (3.27)   3.23 ± 2.37 (3.12)   3.65 ± 3.12 (3.12)   3.65 ± 3.55 (3.55)
  Dihydrocaffeic           0.13 ± 0.13 (0.07)   0.07 ± 0.06 (0.04)   0.07 ± 0.05 (0.05)   0.10 ± 0.07 (0.08)   0.10 ± 0.10 (0.06)   0.09 ± 0.09 (0.06)   0.08 ± 0.06 (0.06)
  Caffeic                  0.11 ± 0.07 (0.09)   0.08 ± 0.05 (0.07)   0.11 ± 0.10 (0.09)   0.12 ± 0.11 (0.10)   0.11 ± 0.08 (0.08)   0.11 ± 0.13 (0.09)   0.09 ± 0.05 (0.07)
  Homovanillic             0.27 ± 0.19 (0.24)   0.29 ± 0.13 (0.20)   0.22 ± 0.11 (0.19)   0.32 ± 0.19 (0.28)   0.28 ± 0.16 (0.26)   0.27 ± 0.10 (0.24)   0.28 ± 0.17 (0.26)
  Vanillic                 0.06 ± 0.07 (0.04)   0.03 ± 0.02 (0.00)   0.04 ± 0.03 (0.00)   0.02 ± 0.03 (0.00)   0.05 ± 0.08 (0.00)   0.03 ± 0.04 (0.00)   0.04 ± 0.06 (0.00)
  DOPAC                    3.75 ± 2.08 (3.54)   2.92 ± 1.46 (2.71)   4.17 ± 3.23 (4.06)   4.17 ± 2.60 (4.08)   3.65 ± 2.29 (3.44)   2.60 ± 1.04 (2.50)   4.27 ± 1.77 (4.06)

DOPAC, 3,4-dihydroxyphenylacetic acid. After a 6 day run-in period volunteers started to consume 500 g of strawberries daily (the first dose on the 6th day and the last dose on the 14th day). On the 15th day, strawberries were withdrawn and subjects entered a wash-out.

###### 

Concentration of selected phenolic acids in spot morning urine of strawberry consumers over the study period

  Phenolic acid (µmol/g of creatinine)   Day of the study                                                                                                                  
  -------------------------------------- ---------------------- -------------------- -------------------- ---------------------- -------------------- -------------------- --------------------
  Hippuric^\#^                           5.8 ± 5.9 (2.0)        2.1 ± 2.3 (1.1)      2.6 ± 3.0 (1.3)      3.7 ± 4.1 (2.3)        2.2 ± 0.9 (2.2)      1.9 ± 0.8 (2.1)      1.7 ± 0.7 (1.8)
  Chlorogenic                            10.7 ± 9.4 (13.7)      6.6 ± 6.4 (7.5)      7.1 ± 8.6 (7.9)      9.2 ± 5.9 (13.8)       5.9 ± 2.1 (7.1)      5.2 ± 2.7 (7.6)      3.9 ± 2.0\* (5.3)
  Dihydrocaffeic                         8.8 ± 9.7 (4.7)        8.2 ± 9.7 (3.3)      6.4 ± 5.6 (5.0)      9.1 ± 9.5 (6.8)        9.2 ± 11.2 (5.3)     11.8 ± 12.3 (9.5)    7.3 ± 6.8 (6.2)
  Caffeic                                7.9 ± 7.1 (5.7)        4.3 ± 4.2 (3.6)      7.1 ± 6.4 (4.3)      10.0 ± 10.7 (7.1)      16.4 ± 24.3 (7.9)    12.1 ± 14.3 (4.3)    6.4 ± 5.0 (4.3)
  Caffeic                                7.9 ± 7.1 (5.7)        4.3 ± 4.2 (3.6)      7.1 ± 6.4 (4.3)      10.0 ± 10.7 (7.1)      16.4 ± 24.3 (7.9)    12.1 ± 14.3 (4.3)    6.4 ± 5.0 (4.3)
  Vanillic                               19.4 ± 15.7 (14.8)     6.6 ± 5.4 (4.9)      11.2 ± 13.1 (5.2)    8.4 ± 6.7 (7.3)        7.5 ± 5.1 (6.4)      12.7 ± 11.6 (7.0)    20.9 ± 28.1 (9.3)
  DOPAC                                  78.3 ± 39.9 (68.7)     70.0 ± 31.1 (56.0)   79.2 ± 42.5 (65.7)   69.9 ± 28.3 (68.3)     72.3 ± 32.2 (69.5)   59.2 ± 19.0 (63.2)   91.6 ± 28.7 (93.9)
  3-hydroxyhippuric                      161.3 ± 161.9 (90.4)   37.2 ± 30.1 (36.6)   49.8 ± 73.1 (20.1)   103.3 ± 107.9 (56.3)   89.6 ± 91.1 (45.8)   71.0 ± 53.9 (46.4)   67.3 ± 85.7 (29.6)

DOPAC, 3,4-dihydroxyphenylacetic acid. After a 6 day run-in period volunteers started to consume 500 g of strawberries daily (the first dose on the 6th day and the last dose on the 14th day). On the 15th day, strawberries were withdrawn and subjects entered a wash-out period lasting until the 21st day. Other details as for Table [3](#T3){ref-type="table"}. ^\#^ results expressed in mmol/g of creatinine. \* vs day 0---*p*\<0.05 and vs day 9th---*p*\<0.01. Changes of 3-hydroxyhippuric acid over the study period were on the border of significance (*p* = 0.057).
